Ming‐Chung Wang
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Hepatology top 5%
- Hepatitis C virus research
Papers in
- Hematology 15
- Chronic Myeloid Leukemia Treatments 7
- Multiple Myeloma Research and Treatments 4
-
- Lymphoma Diagnosis and Treatment 13
- Co-authors
- Ching‐Yuan Kuo (10 shared papers)Ming‐Chun Ma (13 shared papers)Sung‐Nan Pei (9 shared papers)Chien‐Hung Chen (3 shared papers)Chuan–Mo Lee (1 shared paper)Tsung‐Hui Hu (1 shared paper)Wan‐Ting Huang (6 shared papers)Huey‐Ling You (5 shared papers)
- Journals
- Blood (8 papers)Clinical Biochemistry (3 papers)PLoS ONE (2 papers)Experimental and Molecular Pathology (2 papers)Annals of Hematology (2 papers)
- Partner nations
- TaiwanUnited StatesJapan
In The Last Decade
Ming‐Chung Wang
50 papers receiving 1.3k citations
Ming‐Chung Wang's Hit Papers
Peers
Comparison fields: 5 of 92
- Hematology 578
- Hepatology 147
- Oncology 461
- Genetics 160
- Pathology and Forensic Medicine 176
Countries citing papers authored by Ming‐Chung Wang
This map shows the geographic impact of Ming‐Chung Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Chung Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Chung Wang more than expected).
Fields of papers citing papers by Ming‐Chung Wang
This network shows the impact of papers produced by Ming‐Chung Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Chung Wang. The network helps show where Ming‐Chung Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming‐Chung Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study Hit paper breakdown → | 2019 | 516 |
| 2 | 2009 | 179 | |
| 3 | 2021 | 103 | |
| 4 | 2012 | 81 | |
| 5 | 2023 | 53 | |
| 6 | Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies. | 2006 | 47 |
| 7 | 1973 | 32 | |
| 8 | Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial Hit paper breakdown → | 2025 | 32 |
| 9 | 2014 | 30 | |
| 10 | 2010 | 27 | |
| 11 | 2018 | 22 | |
| 12 | Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan. | 2014 | 21 |
| 13 | 2009 | 17 | |
| 14 | 2022 | 16 | |
| 15 | Infectious mononucleosis mimicking malignant T-cell lymphoma in the nasopharynx: a case report and review of the literature. | 2013 | 13 |
| 16 | 2010 | 13 | |
| 17 | 2010 | 12 | |
| 18 | 2013 | 12 | |
| 19 | 2021 | 11 | |
| 20 | 2019 | 11 |
About Ming‐Chung Wang
Ming‐Chung Wang is a scholar working on Hematology, Pathology and Forensic Medicine, Genetics, Oncology and Rheumatology, having authored 52 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (13 papers), Viral-associated cancers and disorders (8 papers), Chronic Myeloid Leukemia Treatments (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Multiple Myeloma Research and Treatments (4 papers), CAR-T cell therapy research (3 papers) and Eosinophilic Disorders and Syndromes (3 papers). The work is most often cited by research in Hematology (578 citations), Hepatology (147 citations), Oncology (461 citations), Genetics (160 citations) and Pathology and Forensic Medicine (176 citations). Ming‐Chung Wang has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Ching‐Yuan Kuo, Ming‐Chun Ma, Sung‐Nan Pei, Chien‐Hung Chen, Chuan–Mo Lee, Tsung‐Hui Hu, Wan‐Ting Huang, Huey‐Ling You, Chun‐Kai Liao and Jien-Wei Liu. Their work appears in journals such as Blood, Clinical Biochemistry, PLoS ONE, Experimental and Molecular Pathology and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.